Abstract:Introduction: Damage to the corneal nerves can result in discomfort and chronic pain, profoundly impacting the quality of life of patients. Development of novel in vitro method is crucial to better understand corneal nerve regeneration and to find new treatments for the patients. Existing in vitro models often overlook the physiology of primary sensory neurons, for which the soma is separated from the nerve endings. Methods: To overcome this limitation, our novel model combines a compartmentalized microfluidic culture of trigeminal ganglion neurons from adult mice with live-imaging and automated 3D image analysis offering robust way to assess axonal regrowth after axotomy. Results: Physical axotomy performed by a two-second aspiration led to a reproducible 70% axonal loss and altered the phenotype of the neurons, increasing the number of substance P-positive neurons 72 h post-axotomy. To validate our new model, we investigated axonal regeneration after exposure to pharmacological compounds. We selected various targets known to enhance or inhibit axonal regrowth and analyzed their basal expression in trigeminal ganglion cells by scRNAseq. NGF/GDNF, insulin, and Dooku-1 (Piezo1 antagonist) enhanced regrowth by 81, 74 and 157%, respectively, while Yoda-1 (Piezo1 agonist) had no effect. Furthermore, SARM1-IN-2 (Sarm1 inhibitor) inhibited axonal regrowth, leading to only 6% regrowth after 72 h of exposure (versus 34% regrowth without any compound). Discussion: Combining compartmentalized trigeminal neuronal culture with advanced imaging and analysis allowed a thorough evaluation of the extent of the axotomy and subsequent axonal regrowth. This innovative approach holds great promise for advancing our understanding of corneal nerve injuries and regeneration and ultimately improving the quality of life for patients suffering from sensory abnormalities, and related conditions.

Advances in Nerve Injury Models on a Chip (adv. Biology 8/2023)

Engineering Three-Dimensional Microenvironments Towards in Vitro Disease Models of the Central Nervous System

Advance of Micro/Nano-Sensing Technology in Study of Tissue Electrophysiology

A Review on Microfluidic Platforms Applied to Nerve Regeneration

Nerve‐on‐a‐Chip Derived Biomimicking Microfibers for Peripheral Nerve Regeneration

Advancing nerve regeneration: Peripheral nerve injury (PNI) chip empowering high-speed biomaterial and drug screening

Microfluidic Manipulation for Biomedical Applications in the Central and Peripheral Nervous Systems

Microfabrication and lab-on-a-chip devices promote in vitro modeling of neural interfaces for neuroscience researches and preclinical applications

Advances in in Vitro Models of Neuromuscular Junction: Focusing on Organ‐on‐a‐Chip, Organoids, and Biohybrid Robotics

Establishment of a Magnetically Controlled Scalable Nerve Injury Model

Microfluidic devices as model platforms of CNS injury-ischemia to study axonal regeneration by regulating mitochondrial transport and bioenergetic metabolism

Innovative Microfluidic Technologies in Precision Research and Therapy Development in Diabetic Neuropathy: a Narrative Review

Assessment of corneal nerve regeneration after axotomy in a compartmentalized microfluidic chip model with automated 3D high resolution live-imaging

Neural Tissue Engineering: from Bioactive Scaffolds and in Situ Monitoring to Regeneration

Development of an in vitro perfusable neural interface model for sequential connection of nerve cells

[Advances and New Ideas of Neurobiology Scaffold in Repair of Nerve Injury].

Nano-Engineered Environment for Nerve Regeneration: Scaffolds, Functional Molecules and Stem Cells

An experimental model of peripheral nerve electrical injury in rats

Inside Front Cover: Neural tissue engineering: From bioactive scaffolds and in situ monitoring to regeneration (EXP2 3/2022)

In Vitro Models for Peripheral Nerve Regeneration

A neurovascular unit-on-a-chip: culture and differentiation of human neural stem cells in a three-dimensional microfluidic environment